Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Giovanni Damiani and Piergiorgio Malagoli.
Giovanni Damiani
Connection Strength
2.572
Piergiorgio Malagoli
  1. COVID-19 vaccination and patients with psoriasis under biologics: real-life evidence on safety and effectiveness from Italian vaccinated healthcare workers. Clin Exp Dermatol. 2021 08; 46(6):1106-1108.
    View in: PubMed
    Score: 0.938
  2. Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: Real-life data from a large cohort during red-zone declaration. Dermatol Ther. 2020 09; 33(5):e13475.
    View in: PubMed
    Score: 0.883
  3. COVID-19 vaccines do not trigger psoriasis flares in patients with psoriasis treated with apremilast. Clin Exp Dermatol. 2021 10; 46(7):1344-1346.
    View in: PubMed
    Score: 0.237
  4. Masks use and facial dermatitis during COVID-19 outbreak: is there a difference between CE and non-CE approved masks? Multi-center, real-life data from a large Italian cohort. Ital J Dermatol Venerol. 2021 Apr; 156(2):220-225.
    View in: PubMed
    Score: 0.234
  5. COVID-19 knowledge prevents biologics discontinuation: Data from an Italian multicenter survey during RED-ZONE declaration. Dermatol Ther. 2020 Jul; 33(4):e13508.
    View in: PubMed
    Score: 0.221
  6. SARS-CoV-2 Infection Induces Psoriatic Arthritis Flares and Enthesis Resident Plasmacytoid Dendritic Cell Type-1 Interferon Inhibition by JAK Antagonism Offer Novel Spondyloarthritis Pathogenesis Insights. Front Immunol. 2021; 12:635018.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.